Mass-Spectrometric MRM Analysis of FDA-Approved Proteins in Plasma of Healthy Volunteers.

Autor: Novikova, S. E., Farafonova, T. E., Tikhonova, O. V., Shushkova, N. A., Pyatnitsky, M. A., Zgoda, V. G., Ponomarenko, E. A., Lisitsa, A. V., Grigoryev, A. I., Tutelyan, V. A., Archakov, A. I.
Zdroj: Biochemistry (Biokhimiya). Supplemental Series B, Biomedical Chemistry; Jan2021, Vol. 15 Issue 1, p40-61, 22p
Abstrakt: The proteomic composition of a biological sample serves as the most important feature of a biological object, and it allows discriminating normal and pathological conditions. Targeted mass spectrometric analysis, particularly, multiple reaction monitoring (MRM) using synthetic stable isotope-labeled internal standards (SIS), is the main alternative to the ELISA method for analysis of diagnostically significant proteins. Based on the MRM results, a prototype test system has been developed; it employs the targeted mass spectrometric method for multiplex, quantitative analysis of FDA-approved proteins in whole plasma. Using this approach, it was possible to measure the content of 42 proteins in 31 samples in a concentration range spanning five orders of magnitude. The interindividual variability for 30 of the 42 registered proteins was less than 40%. The largest scatter was observed for haptoglobin (68%), immunoglobulin heavy constant delta IGHD (90%), angiotensin (72%), sex hormone-binding globulin SHBG (100%), and lipoprotein-(a) (136%). The obtained results on the concentration of proteins correlate with published data (Hortin et al., Clinical Chemistry, 2008, vol. 54, 1608) with R2 = 0.84. The developed prototype test system based on targeted mass spectrometric analysis of proteins can be considered as an alternative to methods using monoclonal antibodies. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index
Externí odkaz: